Cover Image
Market Research Report

Nerve Repair and Regeneration Market, by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery) - Global Forecast to 2022

Published by MarketsandMarkets Product code 281743
Published Content info 123 Pages
Delivery time: 1-2 business days
Price
Back to Top
Nerve Repair and Regeneration Market, by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery) - Global Forecast to 2022
Published: November 10, 2017 Content info: 123 Pages
Description

The nerve repair and regeneration market is expected to reach USD 10.59 million by 2022 from USD 5.79 billion in 2017, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, technological advancements, and rising geriatric population are driving the growth of this market. On the other hand, donor-site morbidity, difficulties in treating large nerve gaps, and stringent regulatory frameworks and time-consuming approval processes may challenge the growth of the market.

Neurostimulation and neuromodulation devices segment is expected to account for the largest share in the market

On the basis of product, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. In 2017, the neurostimulation and neuromodulation devices segment is expected to account for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders and favorable reimbursement policies.

Internal neurostimulation and neuromodulation surgeries segment is expected to register the highest CAGR during the forecast period

Based on application, the nerve repair and regeneration market is segmented into into internal neurostimulation and neuromodulation surgeries and external neurostimulation and neuromodulation surgeries. The internal neurostimulation and neuromodulation surgeries segment is expected to register highest growth rate during the forecast period. This growth can be attributed to its wide application in neurological disorders.

North America is expected to account for the largest regional segment in the market

Geographically, the nerve repair and regeneration market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and growing incidence of peripheral nerve injuries.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 35%, Tier 2 - 22% and Tier 3 - 43%
  • By Designation - C level - 15%, Director level - 32%, Others - 53%
  • By Region - North America - 32%, Europe - 27%, Asia - 22%, RoW - 19%

Key players operating in the nerve repair and regeneration market include: Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (UK), Baxter (US), AxoGen (US), and Stryker (US).

Study Coverage:

The report analyses the nerve repair and regeneration market by product, applications, end user, and regions. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: The report analyzes the nerve repair and regeneration market by product, application, and end user
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the nerve repair and regeneration market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various nerve repair and regeneration product across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the nerve repair and regeneration market.
Table of Contents
Product Code: MD 3642

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NERVE REPAIR AND REGENERATION: MARKET OVERVIEW
  • 4.2. ASIAN NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION AND COUNTRY
  • 4.3. GLOBAL NERVE REPAIR AND REGENERATION MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. NERVE GRAFTING MARKET, BY TYPE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence of nerve injuries
      • 5.2.1.2. Rising geriatric population and subsequent growth in prevalence of neurological disorders
      • 5.2.1.3. Technological advancements
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Greater preference for drug therapies over nerve repair and regeneration products
      • 5.2.2.2. Dearth of trained professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Potential of stem cell therapy in nerve repair and regeneration
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Donor-site morbidity
      • 5.2.4.2. Difficulties in treating large nerve gaps
      • 5.2.4.3. Stringent regulatory frameworks and time-consuming approval processes

6. NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. NEUROSTIMULATION AND NEUROMODULATION DEVICES
    • 6.2.1. INTERNAL NEUROSTIMULATION DEVICES
      • 6.2.1.1. Spinal cord stimulation
      • 6.2.1.2. Deep brain stimulation
      • 6.2.1.3. Vagus nerve stimulation
      • 6.2.1.4. Sacral nerve stimulation
      • 6.2.1.5. Gastric electrical stimulation
    • 6.2.2. EXTERNAL NEUROSTIMULATION DEVICES
      • 6.2.2.1. TENS
      • 6.2.2.2. TMS
  • 6.3. BIOMATERIALS
    • 6.3.1. NERVE CONDUITS
    • 6.3.2. NERVE PROTECTORS
    • 6.3.3. NERVE WRAPS
    • 6.3.4. NERVE CONNECTORS

7. NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.1. INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.2. EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
  • 7.3. DIRECT NERVE REPAIR/NEURORRHAPHY
    • 7.3.1. EPINEURAL REPAIR
    • 7.3.2. PERINEURAL REPAIR
    • 7.3.3. GROUP FASCICULAR REPAIR
  • 7.4. NERVE GRAFTING
    • 7.4.1. AUTOGRAFTS
    • 7.4.2. ALLOGRAFTS
    • 7.4.3. XENOGRAFTS
  • 7.5. STEM CELL THERAPY

8. NERVE REPAIR AND REGENERATION MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS & CLINICS
  • 8.3. AMBULATORY SURGERY CENTERS

9. NERVE REPAIR AND REGENERATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA (ROA)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. REGULATORY APPROVALS
    • 10.3.2. MERGERS AND ACQUISITIONS
    • 10.3.3. PRODUCT LAUNCHES
    • 10.3.4. AGREEMENTS, COLLABORATION AND PARTNERSHIPS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. AXOGEN
  • 11.2. BAXTER
  • 11.3. BOSTON SCIENTIFIC
  • 11.4. LIVANOVA
  • 11.5. INTEGRA LIFESCIENCES
  • 11.6. MEDTRONIC
  • 11.7. ABBOTT LABORATORIES
  • 11.8. STRYKER
  • 11.9. POLYGANICS
  • 11.10. NUVECTRA
  • 11.11. NEUROPACE
  • 11.12. ORTHOMED
  • 11.13. NEVRO

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 12: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: TENS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: TMS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 16: BIOMATERIALS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NERVE CONDUITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NERVE PROTECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NERVE WRAPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NERVE CONNECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 22: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 23: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: EPINEURAL REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: PERINEURAL REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GROUP FASCICULAR REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NERVE GRAFTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 32: NERVE GRAFTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: AUTOGRAFTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: ALLOGRAFTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: XENOGRAFT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: STEM CELL THERAPY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 38: NERVE REPAIR AND REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: NERVE REPAIR AND REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: US: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: NEUROLOGICAL CONDITIONS IN CANADA
  • TABLE 51: CANADA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: EUROPE: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 67: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 68: CHINA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 69: JAPAN: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: INDIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: ROA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: ROW: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 73: ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: ROW: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ROW: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ROW: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: ROW: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 78: ROW: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: GROWTH STRATEGY MATRIX, 2014-2017
  • TABLE 80: REGULATORY APPROVAL, 2014-2017
  • TABLE 81: MERGERS AND ACQUISITIONS, 2014-2017
  • TABLE 82: PRODUCT LAUNCHES, 2014-2017
  • TABLE 83: AGREEMENTS, COLLABORATION, AND PARTNERSHIPS, 2014-2017

LIST OF FIGURES

  • FIGURE 1: NERVE REPAIR & REGENERATION MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN: NERVE REPAIR & REGENERATION MARKET
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: HIGH INCIDENCE OF NERVE INJURIES AND GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
  • FIGURE 12: NEUROSTIMULATION AND NEUROMODULATION SURGERIES TO DOMINATE MARKET IN 2017 (USD BILLION)
  • FIGURE 13: ASIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14: XENOGRAFTS TO CONTINUE REGISTERING HIGHEST GROWTH DURING FORECAST PERIOD (USD BILLION)
  • FIGURE 15: NERVE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: NEUROSTIMULATION AND NEUROMODULATION DEVICES SEGMENT HOLDS LARGEST MARKET SHARE
  • FIGURE 17: NEUROSTIMULATION AND NEUROMODULATION SURGERIES APPLICATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18: HOSPITALS & CLINICS SEGMENT TO DOMINATE NERVE REPAIR AND REGENERATION MARKET DURING FORECAST PERIOD (USD MILLION)
  • FIGURE 19: NORTH AMERICA TO DOMINATE GLOBAL NERVE REPAIR AND REGENERATION MARKET IN 2017 (USD MILLION)
  • FIGURE 20: ASIA NERVE REPAIR AND REGENERATION MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (USD MILLION)
  • FIGURE 21: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 22: ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 23: NERVE REPAIR AND REGENERATION MARKET SHARE, BY PLAYER (2016)
  • FIGURE 24: AXOGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 25: BAXTER: COMPANY SNAPSHOT (2016)
  • FIGURE 26: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 27: LIVANOVA: COMPANY SNAPSHOT (2016)
  • FIGURE 28: INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2016)
  • FIGURE 29: MEDTRONIC: COMPANY SNAPSHOT (2016)
  • FIGURE 30: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 31: STRYKER: COMPANY SNAPSHOT (2016)
  • FIGURE 32: NERVO: COMPANY SNAPSHOT (2016)
Back to Top